144 related articles for article (PubMed ID: 35927694)
1. Clinical observations on infliximab treatment of infantile onset Takayasu arteritis.
Kang M; Lai J; Zhang D; Xu Y; Zhu J; Li M
Pediatr Rheumatol Online J; 2022 Aug; 20(1):61. PubMed ID: 35927694
[TBL] [Abstract][Full Text] [Related]
2. [Infliximab in infantile Takayasu arteritis: a case report and literature review].
Li M; Sun XF; Xu YJ; Hou J; Zhang D; Chi Y; Zhu J; Kang M; Li SN; Su GX; Zhou ZX; Lai JM
Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):1001-1005. PubMed ID: 33256323
[No Abstract] [Full Text] [Related]
3. Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature.
Minami N; Nakase H; Yoshino T; Yamada S; Toyonaga T; Honzawa Y; Matsuura M; Chiba T
Clin J Gastroenterol; 2013 Jun; 6(3):226-30. PubMed ID: 26181600
[TBL] [Abstract][Full Text] [Related]
4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
5. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
7. Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.
Horai Y; Satoru O; Lapalme-Remis S; Sumiyoshi R; Nakashima Y; Suzuki T; Okada A; Kawashiri SY; Ichinose K; Tamai M; Yamasaki S; Nakamura H; Takeshima F; Origuchi T; Kawakami A
Mod Rheumatol; 2013 May; 23(3):572-6. PubMed ID: 22718488
[TBL] [Abstract][Full Text] [Related]
8. Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report.
Masui S; Yonezawa A; Izawa K; Hayakari M; Asakura K; Taniguchi R; Isa M; Shibata H; Yasumi T; Nishikomori R; Takita J; Matsubara K
J Pharm Health Care Sci; 2019; 5():9. PubMed ID: 31073411
[TBL] [Abstract][Full Text] [Related]
9. Infantile Takayasu: clinical features and long-term outcome.
Miller-Barmak A; Sztajnbok F; Balik Z; Borzutzky A; Fogel LA; Goldzweig O; Ozen S; Butbul Aviel Y
Rheumatology (Oxford); 2023 Sep; 62(9):3126-3132. PubMed ID: 36495199
[TBL] [Abstract][Full Text] [Related]
10. Giant aortic aneurysm in a child with Takayasu arteritis.
Halaweish I; Patel H; Si MS
Cardiol Young; 2016 Mar; 26(3):593-5. PubMed ID: 26365418
[TBL] [Abstract][Full Text] [Related]
11. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis.
Jolly M; Curran JJ
J Clin Rheumatol; 2005 Aug; 11(4):213-5. PubMed ID: 16357759
[TBL] [Abstract][Full Text] [Related]
12. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
[TBL] [Abstract][Full Text] [Related]
13. Sudden death of an infant with coronary involvement due to Takayasu arteritis.
Wang EL; Sato Y; Takeichi T; Kitamura O
Cardiovasc Pathol; 2013; 22(1):109-11. PubMed ID: 22717378
[TBL] [Abstract][Full Text] [Related]
14. Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review.
Chapelon-Abric C; Saadoun D; Marie I; Comarmond C; Desbois AC; Domont F; Savey L; Cacoub P
Int J Rheum Dis; 2018 Mar; 21(3):740-745. PubMed ID: 28791773
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging of Takayasu Arteritis in a Patient with Ulcerative Rectocolitis.
Monti L; Servillo R; Grazzini I; Khader L; Acampa M; Cerase A
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e129-e132. PubMed ID: 28479185
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM).
Campochiaro C; Tomelleri A; Sartorelli S; Sembenini C; Papa M; Fallanca F; Picchio M; Cavalli G; De Cobelli F; Baldissera E; Dagna L
Front Med (Lausanne); 2021; 8():723506. PubMed ID: 34646844
[No Abstract] [Full Text] [Related]
17. Takayasu arteritis with coronary aneurysms causing acute myocardial infarction in a young man.
Ouali S; Kacem S; Ben Fradj F; Gribaa R; Naffeti E; Remedi F; Laaoueni C; Boughzela E
Tex Heart Inst J; 2011; 38(2):183-6. PubMed ID: 21494533
[TBL] [Abstract][Full Text] [Related]
18. Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center.
Takai C; Ito S; Kobayashi D; Nemoto T; Lee H; Abe A; Otani H; Nakazono K; Murasawa A; Ishikawa H
Intern Med; 2020; 59(16):1963-1970. PubMed ID: 32801270
[TBL] [Abstract][Full Text] [Related]
19. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
Miraldi Utz V; Bulas S; Lopper S; Fenchel M; Sa T; Mehta M; Ash D; Lovell DJ; Kaufman AH
Pediatr Rheumatol Online J; 2019 Nov; 17(1):79. PubMed ID: 31783768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
